Study of COPD Subgroups and Biomarkers

Active, not recruitingOBSERVATIONAL
Enrollment

2,981

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
COPDChronic Obstructive Pulmonary DiseaseChronic BronchitisEmphysema
Trial Locations (12)

10032

Columbia University, New York

19140

Temple University, Philadelphia

21224

Johns Hopkins University, Baltimore

27157

Wake Forest University, Winston-Salem

35249

University of Alabama at Birmingham, Birmingham

48109

University of Michigan, Ann Arbor

52242

University of Iowa, Iowa City

60612

University of Illinois at Chicago, Chicago

80206

National Jewish Health, Denver

84132

University of Utah, Salt Lake City

90095

University of California at Los Angeles, Los Angeles

94143

University of California at San Francisco, San Francisco

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

COPD Foundation

OTHER

collaborator

Columbia University

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

National Jewish Health

OTHER

collaborator

Temple University

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

University of Illinois at Chicago

OTHER

collaborator

University of Iowa

OTHER

collaborator

University of Michigan

OTHER

collaborator

University of Utah

OTHER

collaborator

Wake Forest University

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT01969344 - Study of COPD Subgroups and Biomarkers | Biotech Hunter | Biotech Hunter